Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies

Wang, Xiaoling, Das, Tapan K., Singh, Satish K., Kumar, Sandeep·2009·mAbs

Cited by (198)

Items 101–198 of 198

  1. An in-silico method for identifying aggregation rate enhancer and mitigator mutations in proteins
    Puneet Rawat, Sandeep Kumar, M. Michael Gromiha · 2018 · International Journal of Biological Macromolecules
  2. Computational re-design of protein structures to improve solubility
    Susanna Navarro, Salvador Ventura · 2019 · Expert Opinion on Drug Discovery
  3. 6thAnnual European Antibody Congress 2010
    Alain Beck, Thierry Wurch · 2011 · mAbs
  4. Large Molecule Specific Assay Operation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team
    Lauren F. Stevenson, Marian M. Kelley, Boris Gorovits, Clare Kingsley, Heather A. Myler, Karolina Österlund, Arumugam Muruganandam, Yoshiyuki Minamide, M. Domínguez · 2013 · The AAPS Journal
  5. RPLC of Intact Proteins Using Sub-0.5 μm Particles and Commercial Instrumentation
    Benjamin J. Rogers, Robert E. Birdsall, Zhen Jiang Wu, Mary J. Wirth · 2013 · Analytical Chemistry
  6. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody
    Ronald T. Toth, Samantha E. Pace, Brittney J. Mills, Sangeeta B. Joshi, Reza Esfandiary, Charles Russell Middaugh, David D. Weis, David B. Volkin · 2017 · Journal of Pharmaceutical Sciences
  7. Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability
    Greg P. Conley, Malini Viswanathan, Ying Hou, Doug L. Rank, Allison P Lindberg, Steve M. Cramer, Robert C. Ladner, Andrew E. Nixon, Jie Chen · 2011 · Biotechnology and Bioengineering
  8. Investigating the colloidal stability of fluorescent silica nanoparticles under isotonic conditions for biomedical applications
    Robert I. Nooney, Angela White, Christy M. O’Mahony, Claire O’Connell, Susan M. Kelleher, Stephen M. Daniels, Colette M. McDonagh · 2015 · Journal of Colloid and Interface Science
  9. Predicting the expression of recombinant monoclonal antibodies in Chinese hamster ovary cells based on sequence features of the CDR3 domain
    Leon P. Pybus, David C. James, Greg Dean, Timothy W.F. Slidel, Colin H. Hardman, Andrew B Smith, Olalekan Daramola, Ray P. Field · 2013 · Biotechnology Progress
  10. Oxidation-Induced Destabilization of Model Antibody-Drug Conjugates
    Jakob W. Buecheler, Matthias Winzer, Christian Weber, Henning Gieseler · 2018 · Journal of Pharmaceutical Sciences
  11. Identification and Impact of Aggregation‐Prone Regions in Proteins and Therapeutic Monoclonal Antibodies
    Sandeep Kumar, Xiaoling Wang, Satish Kumar Singh · 2010
  12. A Review on Mixing-Induced Protein Particle Formation: The Puzzle of Bottom-Mounted Mixers
    Benson Gikanga, Yuh‐Fun Maa · 2020 · Journal of Pharmaceutical Sciences
  13. Optimization of size, morphology and colloidal stability of fluorescein dye-doped silica NPs for application in immunoassays
    Robert I. Nooney, E Siobhan McCormack, Colette M. McDonagh · 2012 · Analytical and Bioanalytical Chemistry
  14. Long-Term Stability of Anti-Vascular Endothelial Growth Factor (a-VEGF) Biologics Under Physiologically Relevant Conditions and Its Impact on the Development of Long-Acting Delivery Systems
    Debby P. Chang, Shalini Burra, Eric S. Day, Joyce Chan, Laëtitia Comps‐Agrar, Thierry Nivaggioli, Karthikan Rajagopal · 2020 · Journal of Pharmaceutical Sciences
  15. Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation
    Dezhi Li, Rui Gong, Jun Zheng, Xihai Chen, Dimiter Stanchev Dimitrov, Qi Zhao · 2017 · Biochemical and Biophysical Research Communications
  16. Prediction of protein binding regions
    Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser, Bernhard Helk, Bernhardt L. Trout · 2010 · Proteins Structure Function and Bioinformatics
  17. Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry
    Apurva S. More, Ronald T. Toth, Solomon Z. Okbazghi, Charles Russell Middaugh, Sangeeta B. Joshi, Thomas J. Tolbert, David B. Volkin, David D. Weis · 2018 · Journal of Pharmaceutical Sciences
  18. Cell culture media impact on drug product solution stability
    Jennifer Purdie, Ronald L. Kowle, Amie L. Langland, Chetan N. Patel, Anli Ouyang, Donald J. Olson · 2016 · Biotechnology Progress
  19. Clear insight into complex multimodal resins and impurities to overcome recombinant protein purification challenges: A review
    Maryam Moazami Goodarzi, R. Jalalirad · 2024 · Biotechnology and Bioengineering
  20. Development of antibody arrays for monoclonal antibody Higher Order Structure analysis
    Xing Wang, Qing Li, Michael Davies · 2013 · Frontiers in Pharmacology
  21. PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning
    Bian Li, Shukun Luo, Wenhua Wang, Jiahui Xu, Dingjiang Liu, Mohammed Shameem, John Mattila, Matthew C. Franklin, Peter G. Hawkins, Gurinder S. Atwal · 2025 · mAbs
  22. Functions of Gle1 are governed by two distinct modes of self-association
    Aaron C. Mason, Susan R. Wente · 2020 · Journal of Biological Chemistry
  23. Next-generation optimized biotherapeutics — A review and preclinical study
    Tadashi Ueda · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  24. Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions
    Laila Ismail Sakhnini, Per Jr Greisen, Charlotte Wiberg, Zoltán Bozóky, Søren Lund, Adriana-Michelle Wolf Pérez, Hanne Sophie Karkov, Kasper Huus, Hansen Jens-Jacob, Leif Bülow et al. · 2019 · Biochemistry
  25. Insights into the potential aggregation liabilities of the b12 Fab fragment via elevated temperature molecular dynamics
    Patrick M. Buck, Sandeep Kumar, Satish Kumar Singh · 2012 · Protein Engineering Design and Selection
  26. Optimizing selectivity of anion hydrophobic multimodal chromatography for purification of a single‐chain variable fragment
    Laila Ismail Sakhnini, Anja Kallesøe Pedersen, Ileana R. León, Per Jr Greisen, Jens Jacob Hansen, Malene Bech Vester-Christensen, Leif Bülow, Maria B. Dainiak · 2019 · Engineering in Life Sciences
  27. Monoclonal Antibodies: A Prospective and Retrospective View
    Sivaccumar, Jwala, Sandomenico, Annamaria, Vitagliano, Luigi, Ruvo, Menotti · 2021 · Current Medicinal Chemistry
  28. Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances
    Eugenio Gallo · 2024 · Molecular Biotechnology
  29. Factors to Govern Soluble and Insoluble Aggregate-formation in Monoclonal Antibodies
    Jun Fukuda, Takafumi Iwura, Shigehiro Yanagihara, Kenji Kano · 2015 · Analytical Sciences
  30. Formulation of proteins and monoclonal antibodies (mAbs)
    Steven J. Shire · 2015 · Elsevier eBooks
  31. Differences between reversible (self-association) and irreversible aggregation of rHuG-CSF in carbohydrate and polyol formulations
    Renata Pavišić, Ivana Dodig, Anita Horvatić, Lucija Mijić, Mirela Sedić, Maša Rajić Linarić, Ita Gruic‐Sovulj, Tajana Preočanin, Mirjana Bukvić Krajačić, Mario Cindrić · 2010 · European Journal of Pharmaceutics and Biopharmaceutics
  32. A polar ring endows improved specificity to an antibody fragment
    Zachary P. Schaefer, Lucas J. Bailey, Anthony A. Kossiakoff · 2016 · Protein Science
  33. Surfaces Affect Screening Reliability in Formulation Development of Biologics
    Mitja Zidar, Gregor Posnjak, Igor Muševič, Miha Ravnik, Drago Kuzman · 2020 · Pharmaceutical Research
  34. Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain
    Kazumasa Sakurai, Ryosuke Nakahata, Young‐Ho Lee, József Kardos, Takahisa Ikegami, Yuji Goto · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  35. Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAb
    Wenkui Lan, Joseph J. Valente, Andrew J. Ilott, Naresh Chennamsetty, Zhihua Liu, Joseph M. Rizzo, Aaron P. Yamniuk, Difei Qiu, Holly Merideth Shackman, Mark S. Bolgar · 2020 · mAbs
  36. Interaction of a Macrocycle with an Aggregation-Prone Region of a Monoclonal Antibody
    Marcello Martinez Morales, Matja Zalar, Silvia Sonzini, Alexander P. Golovanov, Christopher F. van der Walle, Jeremy P. Derrick · 2019 · Molecular Pharmaceutics
  37. Characterization of Monoclonal Antibody Aggregates and Emerging Technologies
    Richard L. Remmele, Jared S. Bee, Jonathan J. Phillips, Wenjun Mo, Daniel R. Higazi, Jifeng Zhang, Viv Lindo, Alistair D. Kippen · 2015 · ACS symposium series
  38. CISI: A Tool for Predicting Cross-interaction or Self-interaction of Monoclonal Antibodies Using Sequences
    Anthony Mackitz Dzisoo, Bifang He, Rita Karikari, Elijah Agoalikum, Jian Hua Huang · 2019 · Interdisciplinary Sciences Computational Life Sciences
  39. Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
    Sang Il Kim, Sujeong Kim, Jinhee Kim, So Young Chang, Jung Min Shim, Jongwha Jin, Chungsu Lim, Song‐Yi Baek, Ji-Young Min, Wan Beom Park et al. · 2019 · International Journal of Molecular Sciences
  40. Capture of the Human IgG1 Antibodies by Protein A for the Kinetic Study of h-IgG/FcγR Interaction Using SPR-Based Biosensor Technology
    Thierry Champion, Alain Beck · 2013 · Methods in molecular biology
  41. Temperature‐Dependent Molecular Adaptations, Microbial Proteins
    Sandeep Kumar, Satish Kumar Singh, M. Michael Gromiha · 2010 · Wiley eBooks
  42. Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants
    Michaela Blech, Richard Melien, Nuška Tschammer, Beate Presser, Dariush Hinderberger, Patrick Garidel · 2021 · Pharmaceutical Research
  43. Single-chain dimers from de novo immunoglobulins as robust scaffolds for multiple binding loops
    Jorge Roel‐Touris, Marta Nadal, Enrique Marcos · 2023 · Nature Communications
  44. Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease
    Kate L. Sheehan, HyeSook Jeon, S. Corr, Jerrard M. Hayes, K.-H. Mok · 2024 · The Protein Journal
  45. Highly variable aggregation and glycosylation profiles and their roles in immunogenicity to protein-based therapeutics
    Sina Sarsarshahi, Sanghati Bhattacharya, Zeb Ralph Zacharias, Eman S. Kamel, Jon C. D. Houtman, M. Reza Nejadnik · 2025 · Journal of Pharmaceutical Sciences
  46. Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics
    Subramaniyan Manibalan, Thirukumaran Kandasamy, Mathimaran Varshni, Ayyasamy Shobana, Anant Achary · 2020 · Biotechnology and Genetic Engineering Reviews
  47. Antibody interfaces revealed through structural mining
    Yizhou Yin, Matthew G. Romei, Kannan Sankar, Lipika R. Pal, Kam Hon Hoi, Yanli Yang, Brandon C. Leonard, Gladys de Leon Boenig, Nikit Kumar, Marissa Matsumoto et al. · 2022 · Computational and Structural Biotechnology Journal
  48. Quantum Dot-Based Immunoassays: Unraveling Sensitivity Discrepancies and Charting Future Frontiers
    Mei Dang, Longjiang Wu, Gelin Jin, Chenxuan Yang, Murtala Bindawa Isah, Xiaoying Zhang · 2024 · Analytical Chemistry
  49. Classification model of amino acid sequences prone to aggregation of therapeutic proteins
    Monika Marczak, Krystyna Okoniewska, Tomasz Grabowski · 2016 · In Silico Pharmacology
  50. In silico Techniques for Prospecting and Characterizing Monoclonal Antibodies
    Tânia Maria Manieri, Carolina Georg Magalhães, Daniela Yumi Takata, João Victor Batalha-Carvalho, Ana Maria Moro · 2020 · IntechOpen eBooks
  51. Identification of monoclonal antibody variants involved in aggregate formation – Part 2: Hydrophobicity variants
    Robina M. Meyer, Lukas Berger, Joerg Nerkamp, Stefan Scheler, Sebastian Nehring, Wolfgang Frieß · 2021 · European Journal of Pharmaceutics and Biopharmaceutics
  52. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains
    Johan Nilvebrant, June Ereño‐Orbea, Maryna Gorelik, Mark C. Julian, Peter M. Tessier, Jean‐Philippe Julien, Sachdev S. Sidhu · 2021 · Journal of Molecular Biology
  53. Developability in biophysical characterization
    Deniz B. Temel, Francis S. Kinderman, Ertan Eryilmaz · 2019 · Elsevier eBooks
  54. In Silico Analysis of Therapeutic Antibody Aggregation and the Influence of Glycosylation
    Hyesoo Jeon, Jerrard M. Hayes, K. Hun Mok · 2021 · Methods in molecular biology
  55. Heterogeneity of IgGs: Role of Production, Processing, and Storage on Structure and Function
    Chris Barton, David Spencer, Sophia V. Levitskaya, Jinhua Feng, Reed J. Harris, Mark A. Schenerman · 2014 · ACS symposium series
  56. Investigating Local Sequence‐Structural Attributes of Amyloidogenic Light Chain Variable Domains
    Puneet Rawat, R. Prabakaran, Divya Sharma, Vasanth Mandala, Victor Greiff, Sandeep Kumar, M. Michael Gromiha · 2025 · Proteins Structure Function and Bioinformatics
  57. Potential aggregation hot spots in recombinant human keratinocyte growth factor: a computational study
    Mansoureh Shahbazi Dastjerdeh, Mohammad Ali Shokrgozar, Hamzeh Rahimi, Majid Golkar · 2021 · Journal of Biomolecular Structure and Dynamics
  58. Effect of charged mutation on aggregation of a pentapeptide: Insights from molecular dynamics simulations
    R. Prabakaran, Puneet Rawat, Nobuaki Yasuo, Masakazu Sekijima, Sandeep Kumar, M. Michael Gromiha · 2021 · Proteins Structure Function and Bioinformatics
  59. Micro-Heterogeneity of Antibody Molecules
    Yusuke Mimura, Radka Saldova, Yuka Mimura‐Kimura, Pauline Mary Rudd, Roy Jefferis · 2021 · Experientia supplementum
  60. Development of ophthalmic formulations
    Paramita Bandyopadhyay, Martin J. Coffey, Mohannad Shawer · 2012 · CRC Press eBooks
  61. Solubility and Early Assessment of Stability for Protein Therapeutics
    Sheng‐Jiun Wu, Gary L. Gilliland, Yiqing Feng · 2014
  62. Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection
    Boonlert Lumlertdacha, Bancha Mahong, Kaewta Rattanapisit, Christine Joy I. Bulaon, Thiravat Hemachudha, Waranyoo Phoolcharoen · 2023 · Vaccines
  63. Chapter 1: Monoclonal Antibodies: Structure, Physicochemical Stability, and Protein Engineering
    Brittney J. Mills, Ehab M. Moussa, Feroz Jameel · 2020 · AAPS advances in the pharmaceutical sciences series
  64. The study of degradation mechanisms of glyco-engineered plant produced anti-rabies monoclonal antibodies E559 and 62-71-3
    Sindisiwe G. Buthelezi, Heini W. Dirr, Ereck Chakauya, Rachel Chikwamba, Lennart Martens, Tsepo Lebiletsa Tsekoa, Elien Vandermarliere, Stoyan Stoychev · 2018 · PLoS ONE
  65. Biopharmaceutical Informatics: Applications of Computation in Biologic Drug Development
    Sandeep Kumar, Russell P. Robins, Patrick M. Buck, Timothy Paul Hickling, Anthony Mary Thangakani, Li Li, Satish Kumar Singh, M. Michael Gromiha · 2015 · CRC Press eBooks
  66. Preclinical Immunogenicity Risk Assessement of Biotherapeutics
    Tim D. Jones, Anette Christine Karle, Matthew Baker · 2015 · CRC Press eBooks
  67. Site-Specific Structural Changes in Long-Term-Stressed Monoclonal Antibody Revealed with DEPC Covalent-Labeling and Quantitative Mass Spectrometry
    Manasi Gaikwad, Florian Martin Richter, Rabea M. Götz, Aline Ricarda Dörrbaum, Lena Schumacher, Jason Tonillo, Christian Frech, Roland Kellner, Carsten Hopf · 2023 · Pharmaceuticals
  68. Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem
    Wenbo Jiang, Emily H. Pilkington, Hannah G. Kelly, Hyon‐Xhi Tan, Jennifer A. Juno, Adam K. Wheatley, Stephen John Kent · 2020 · PLoS ONE
  69. Biophysical and biochemical characterization of peptide and protein drug product
    Tapan Kanti Das, James Carroll · 2012 · CRC Press eBooks
  70. Human Antibody Structure and Function
    Ponraj Prabakaran, Dimiter Stanchev Dimitrov · 2017 · Methods and principles in medicinal chemistry
  71. Antibody engineering to generate anti-tumor-associated glycoprotein 72 mouse recombinant CC49 IgG with improved solubility, purity, and thermal stability
    Zhihong Lin, Bailin Tu, Philip M. Hemken, A. Scott Muerhoff · 2023 · Journal of Immunological Methods
  72. Chemically Programmed Fc Protein as Antibody Mimetic to Targeting Carbonic Anhydrase IX
    Hao Wang, Jiajie Song, Yanan Quan, Jiaqi Liu, Wanyi Tai · 2024 · Bioconjugate Chemistry
  73. Evaluation of the Aggregation States of Monoclonal Antibodies by Diverse and Complementary Methods
    Tetsuya Yoshino, Tomoyoshi Ishikawa, Takashi Ishihara, Yoshimi Takeuchi, Hitomi Yoshikawa, Hideaki Yoshida, Hitoshi Yoshida, Kaori Wakamatsu · 2011 · Biological and Pharmaceutical Bulletin
  74. Developability Assessment Workflows to De-Risk Biopharmaceutical Development
    Jesús Zurdo, Andreas Arnell, Olga Obrezanova, Noel Smith, Thomas R. A. Gallagher, Ramón Gómez de la Cuesta, Ben Locwin · 2015 · CRC Press eBooks
  75. Influence of Amino Acid Properties for Characterizing Amyloid Peptides in Human Proteome
    R. Prabakaran, Rahul Nikam, Sandeep Kumar, M. Michael Gromiha · 2017 · Lecture notes in computer science
  76. Biosimilar mAb in-process Sample Higher Order Structure Analysis with Protein Conformational Array ELISA
    Michael Davies, Gan Wang, Jian Ru Gong, Guofeng Fu, Xing Wang · 2015 · Journal of Pharmaceutical Research International
  77. Aggregation Prone Regions in Antibody Sequences Raised Against Vibrio cholerae: A Bioinformatic Approach
    Zakia Akter, Anamul Haque, Md. Sabir Hossain, Firoz Ahmed, Md Asiful Islam · 2020 · Current Bioinformatics
  78. A path to building quality during monoclonal antibody candidate selection
    Alexandre Ambrogelly, Valentyn Antochshuk, Shuangping Shi, Zhong Liu, Mohammed Shameem · 2015
  79. Local environment effects on charged mutations for developing aggregation-resistant monoclonal antibodies
    Jihyeon Lee, Song‐Ho Chong, Sihyun Ham · 2020 · Scientific Reports
  80. Elucidation of the Reversible Self-Association Interface of a Diabody–Interleukin Fusion Protein Using Hydrogen-Exchange Mass Spectrometry and In Silico Modeling
    Martin Eisinger, Harri Rahn, Yong Chen, Melissa Fernandes, Zhiyi Lin, Nikolai Hentze, Davide Tavella, Ehab M. Moussa · 2024 · Molecular Pharmaceutics
  81. Voltammetric Monitoring of Protein Aggregation from Solution Using Tris‐(2,2′‐Bipyridine) Osmium(II) Chloride Complex as an Electrocatalytic Mediator
    Napoleon Tercero, Joseph A. Kotarek · 2014 · Electroanalysis
  82. Cell line development for and characterization of mono- and bivalent antibody derivatives
    Verena Berger · 2013 · OPUS Publication Server of the University of Stuttgart (University of Stuttgart)
  83. Development of methods for the analysis of protein post-translational modific ations: isoaspartic acid and protein crosslinking
    Min Liu · 2014
  84. pH- and temperature-dependent mechanisms of non-native aggregation of anti-CD40 IgG1
    Haixia Wu · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
  85. Current Trends in Antibody Purification and Lead Selection
    Jie Chen, Andrew E. Nixon · 2011 · Modecular medicine and medicinal
  86. Generation and Characterisation of Novel Monoclonal Antibodies towards Ovarian Tumour Stem Cells
    Louisa Luk · 2012
  87. Protein Conformational Array Technology for Biosimilar Higher Order Structure Analysis
    Xing Wang, Wen‐Rong Lie, Jehangir Mistry · 2018 · AAPS advances in the pharmaceutical sciences series
  88. Investigating the immunogenicity of therapeutic proteins : protein aggregation and host cell protein impurities
    Kirsty D. Ratanji · 2017 · Research Explorer (The University of Manchester)
  89. Disulfide bond formation in Escherichia coli
    Bruno Manta, Emily A. Lundstedt, Augusto F. García, James B. Eaglesham, Mehmet Berkmen · 2022 · Elsevier eBooks
  90. Freeze-thaw-induced aggregation of bovine gamma globulin was efficiently inhibited by an intrinsically disordered plant protein dehydrin
    Honami Osuda, Yûki Kimura, Masakazu Hara · 2022 · Food Hydrocolloids for Health
  91. Polymer Antibody Conjugations
    Aman Srikanth Kudada, Gurmeet Singh, Divya Pareek, Desh Deepak Yadav, Sukanya Patra, Anjali Ramsabad Mourya, Taniya Das, Kirti Wasnik, Pradip Paik · 2024 · Elsevier eBooks
  92. Processes of Thermal Aggregation and Autolysis of Cysteine Protease Molecules: Bromelain, Ficin, and Papain
    Marina G. Holyavka, Victoria A. Koroleva, Valeriy G. Artyukhov · 2025 · BIOPHYSICS
  93. Engineering mammalian protein secretion: Toward the convergence of high-throughput biology and computational methods
    Jacopo Gabrielli, Nathan E. Lewis, Cleo Kontoravdi, Francesca Ceroni · 2025 · Cell Systems
  94. Facteurs immunologiques et génétiques impliqués dans la variabilité de la pharmacocinétique des anticorps thérapeutiques
    Charlotte Magdelaine–Beuzelin · 2010
  95. Déterminants moléculaires de la pharmacocinétique des anticorps thérapeutiques
    Guillaume Brachet · 2017
  96. Approches analytiques pour l'analyse et la caractérisation d'anticorps thérapeutiques dégradés : intérêt de la spectrométrie de masse en mode non-dénaturant
    Minh Thang Le · 2019
  97. Etude structurale et fonctionnelle des substances apparentées d’anticorps thérapeutiques
    Grégory Rouby · 2020
  98. kitAb: an automated framework for assay-specific antibody developability modeling and large-scale landscape analysis
    Екатерина Трофимова, Elizaveta V. Shaburova, Денис Антонец, Vasily E. Ramensky · 2026 · bioRxiv (Cold Spring Harbor Laboratory)